House File 2410 - Introduced HOUSE FILE 2410 BY COMMITTEE ON COMMERCE (SUCCESSOR TO HSB 529) A BILL FOR An Act relating to restrictions for drug product selection 1 relative to antiepileptic drugs. 2 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA: 3 TLSB 5240HV (2) 83 pf/nh

H.F. 2410 Section 1. Section 155A.32, Code 2009, is amended by adding 1 the following new subsection: 2 NEW SUBSECTION . 2A. a. The pharmacist shall not exercise 3 the drug product selection described in this section for 4 an antiepileptic drug or formulation of an antiepileptic 5 drug, whether brand name or generic name, prescribed for the 6 treatment of epilepsy, prior to meeting all of the following 7 requirements: 8 (1) Providing notification to the patient or the patient’s 9 representative. 10 (2) Providing notification to the authorized prescriber. 11 b. For the purposes of this subsection, “notification” 12 shall require the pharmacist to provide written or documented 13 verbal communication to the prescriber and patient or patient’s 14 representative at the time the drug is dispensed. Notification 15 to the patient shall include informing the patient or patient’s 16 representative of the patient’s right to reject the drug being 17 dispensed. 18 c. If any part of the prescription under this subsection 19 will be paid by expenditure of public funds authorized under 20 chapter 249A, the rules, policies, and procedures applicable 21 to prescription drugs under that chapter shall apply to a 22 prescription under this subsection. 23 d. This subsection shall apply if the patient’s condition is 24 being treated with a specific drug, strength, dosage form, and 25 dosing regimen from a specific manufacturer. 26 e. For the purposes of this subsection, drug product 27 selection includes dispensing the antiepileptic drug of 28 another manufacturer instead of the antiepileptic drug of the 29 manufacturer which the patient is currently prescribed, and 30 substituting a generic version for a brand version, a brand 31 version for a generic version, or a generic version for a 32 generic version of a different manufacturer. 33 EXPLANATION 34 This bill provides an exception to authorization of drug 35 -1- LSB 5240HV (2) 83 pf/nh 1/ 2

H.F. 2410 product selection by pharmacists by prohibiting such drug 1 product selection for an antiepileptic drug or formulation 2 of an antiepileptic drug, whether brand name or generic 3 name, prescribed for the treatment of epilepsy, unless the 4 pharmacist first provides notification to the patient or the 5 patient’s representative and to the authorized prescriber. The 6 bill specifies the requirements for providing notification, 7 under what conditions the bill applies, and what drug product 8 selection includes under the bill. The bill also provides that 9 if any part of the prescription will be paid by expenditure of 10 public funds authorized under Code chapter 249A (Medicaid), 11 the rules, policies, and procedures applicable to prescription 12 drugs under Code chapter 249A are to apply to the prescription. 13 -2- LSB 5240HV (2) 83 pf/nh 2/ 2